From the Medizinische Klinik and the Institut für Klinische Biochemie und Pathobiochemie der Julius-Maximilians-Universität Würzburg, Germany; and the Deutsches Herzzentrum und 1. Medizinische Klinik, Technische Universität München, Germany.
Chemokines released by the endothelium have proaggregatory properties on platelets. Fractalkine, a recently discovered membrane-bound chemokine with a transmembrane domain, is expressed in vascular injury; however, the effects of fractalkine on platelets have not yet been investigated. Blood was taken from healthy Wistar-Kyoto rats and the expression of the fractalkine receptor on platelets was demonstrated. The modulation of surface expression of P-selectin was assessed by flow cytometry. P-selectin expression was significantly enhanced by in vitro stimulation with recombinant rat fractalkine compared with baseline levels. Selectively inhibiting the function of recombinant fractalkine by an antagonizing antibody or the disruption of the G-protein–coupled intracellular signaling cascade of the fractalkine receptor by pertussis toxin (PTX) completely prevented fractalkine-mediated platelet activation. Preincubation with apyrase significantly attenuated the fractalkine-induced degranulation. In a flow chamber model of platelet adhesion, stimulation with fractalkine significantly enhanced platelet adhesion to collagen and fibrinogen. Similar to P-selectin expression, enhanced adhesion could be prevented by the antagonizing antibody or preincubation of platelets with PTX. Fractalkine, which is overexpressed in atherosclerosis and vascular injury, contributes to platelet activation and adhesion and hence is likely to play a pathophysiologically important role for increased thrombogenesis in vascular diseases.
A novel endoscope manipulator, Naviot, enables solo-surgery to be performed during video-assisted thoracic surgery
Use of tissue welding technology to obliterate left atrial appendage – novel use of LigasureTM
Novel Speckle-Tracking Radial Strain From Routine Black-and-White Echocardiographic Images to Quantify Dyssynchrony and Predict Response to Cardiac Resynchronization Therapy
Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia
A Pilot Study of Hemodynamic and Renal Responses to a Novel Percutaneous Intervention in Decompensated Heart Failure
Antihypertensive Effects of Drospirenone With 17-Estradiol, a Novel Hormone Treatment in Postmenopausal Women With Stage 1 Hypertension
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells
Novel Mutation in Desmoplakin Causes Arrhythmogenic Left Ventricular Cardiomyopathy
Novel Molecular Mechanism Involving 1D (Cav1.3) L-Type Calcium Channel in Autoimmune-Associated Sinus Bradycardia
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention